Spirometer Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer [Incentive, Professional, Wireless, Handheld, Stationary, USB]) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User — Global Forecast to 2031

Spirometer Market Size & Forecast

The Spirometer Market is expected to reach $1.80 billion by 2031, at a CAGR of 9.2% from 2024 to 2031. The growth of this market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals may restrain the market’s growth.

Additionally, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to create market growth opportunities. However, the availability of alternative technologies is a significant challenge impeding the market’s growth.

Moreover, the emergence of wearable spirometer devices and the integration of telehealth and remote monitoring with spirometry are prominent trends in the spirometer market.

Spirometer Market Growth Drivers

Rising Incidence of Respiratory Diseases

The prevalence of respiratory diseases is rising globally. Respiratory diseases are mainly caused due to smoke, infections, air pollution, dust, and chemicals. Some of the most common respiratory diseases are Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, pulmonary fibrosis, pneumonia, bronchitis, cystic fibrosis, and emphysema.

• According to the data published by the World Health Organization (WHO) in 2023, globally, 3.23 million deaths occurred due to COPD in 2019. Further, according to the America Lung Association (ALA), in 2022, 11.7 million people were diagnosed with COPD, chronic bronchitis.
• According to the Australian Bureau of Statistics, in 2022, 2.8 million people had asthma in Australia.
• In 2022, 20.2 million adults and 4.6 million children in the U.S had asthma. (Source: American College of Allergy, Asthma & Immunology). Furthermore, according to the Asthma and Allergy Foundation of America, in 2023, more than 27 million people in the U.S. had asthma.

Thus, the increasing prevalence of respiratory diseases drives the demand for spirometers.

Increasing Awareness Programs Regarding Respiratory Diseases

Numerous organizations have initiated respiratory disease awareness campaigns aimed at educating both patients and the general public about the importance of early detection, prevention, and management of respiratory conditions. For instance,

• In November 2023, the America Lung Association launched the ‘COPD for Life’ program to improve the lives of people living with long-term COPD.
• In September 2023, Alkem Laboratories Ltd (India) launched a campaign to increase awareness about the importance of early diagnosis and treatment of respiratory diseases.
• In May 2023, Cipla Ltd. (India) launched the ‘Tuffies’ campaign to increase pediatric respiratory care awareness and enhance treatment, especially for children with asthma.
• In November 2022, the America Lung Association launched World COPD Day to increase awareness about COPD, particularly the essential need to enhance screening, early diagnosis, and quality of life for those living with COPD.
• In May 2023, the Global Initiative for Asthma (GINA) organized the World Asthma Day (WAD) to increase awareness of asthma.

Thus, the increasing prevalence of respiratory disease awareness programs is expected to drive the growth of the spirometer market.

Click here to: Get Free Sample Pages of this Report

Spirometer Market Trends

Emergence of Wearable Spirometer Devices

Wearable spirometers offer several advantages over traditional spirometry devices. They are portable and compact, allowing individuals to assess their lung function conveniently and flexibly, regardless of their location. This enhanced accessibility enables patients to monitor their respiratory health more frequently, leading to improved management of respiratory diseases and early detection of potential issues. Moreover, the mobility and user-friendly design of wearable spirometers contribute to increased patient compliance and engagement with their healthcare.

Furthermore, wearable spirometers seamlessly integrate with various digital health platforms, including cloud systems and smartphone apps. These integrations facilitate data analysis, synchronization, and reporting, enabling patients to share spirometry test results with healthcare professionals for telemedicine consultations and remote monitoring. Thus, wearable spirometer devices represent a growing trend in the market, offering enhanced convenience and connectivity for respiratory health management.

Integration of Telehealth and Remote Monitoring with Spirometry

With advancements in telehealth and remote monitoring, spirometry can now be conducted and monitored remotely. Telehealth allows spirometry testing to be performed outside of traditional medical settings, providing convenience for patients, especially those with limited mobility or living in remote areas. Patients can undergo tests from the comfort of their homes, eliminating the need for travel.

Moreover, remote monitoring enables healthcare professionals to access real-time data from spirometry tests conducted on patients. This continuous monitoring allows for early detection of any worsening lung function, enabling timely intervention. Healthcare providers can remotely monitor the data and intervene as needed, reducing the risk of complications and improving patient care.

The rising adoption of telehealth and remote monitoring has increased the demand for equipment and software solutions that facilitate remote spirometry testing. Companies are developing spirometers with integrated connectivity features, allowing seamless integration with remote monitoring solutions and telehealth platforms. This trend is expected to continue as healthcare facilities embrace digital health solutions and prioritize remote patient care.

Spirometer Market Opportunities

Partnerships & Collaborations Between Market Players Aimed at Advancing Spirometers

Various companies are focusing on partnerships and collaborations to develop advanced spirometers, such as digital or smart spirometers, to improve patient accessibility and care. For instance,

• In July 2023, The Med Company B.V. (Netherlands) collaborated with OLVG (Netherlands) to integrate the Spirobank Smart Spirometer into the MedCor4U App.
• In August 2022, AstraZeneca (U.K.) partnered with Roundworks Technologies Private Limited (India), Alveofit, to offer IoT-enabled handheld spirometers to hospitals across the country.
• In September 2022, RxCap, Inc. (U.S.) partnered with ZEPHYRx LLC (U.S.) to integrate cloud spirometry into its remote monitoring enablement platform.

Such partnerships and collaborations among companies to advance the capabilities of spirometers are expected to create market growth opportunities.

Spirometer Market Analysis: Key Findings

By Product: In 2024, the Devices Segment to Dominate the Spirometer Market

Based on product, the spirometer market is segmented into devices, consumables & accessories, and software. In 2024, the devices segment is expected to account for the largest share of 65.2% of the spirometer market. This segment’s large market share can be attributed to the increasing approvals of spirometer devices, technological advancements in these devices, and their widespread adoption for monitoring disease progression.

Additionally, the increasing global prevalence of smoking is expected to create opportunities for market growth. According to data released by the World Health Organization (WHO) in July 2023, 8 million individuals succumbed to smoking-related illnesses in 2022, with an additional 1.3 million non-smokers affected by passive smoking. In response, companies operating in this market are launching new spirometers. For instance, in November 2021, Cipla Ltd. (India) launched Spirofy, a portable, wireless spirometer based on pneumotach technology designed to diagnose Chronic Obstructive Pulmonary Disorder (COPD) and asthma.

By Technology: In 2024, the Peak Flow Measurement Segment to Dominate the Spirometer Market

Based on technology, the spirometer market is segmented into volume measurement and peak flow measurement. In 2024, the peak flow measurement segment is expected to account for the larger share of the spirometer market. This segment’s large market share can be attributed to the ease of use, portability, and cost-effectiveness of peak flow measurement spirometers. These devices are simpler to operate and require minimal setup compared to volume-based devices. Manufacturers are also developing spirometers with digital interfaces, allowing for real-time results, which further contribute to the segment’s growth.

By Application: In 2024, the Chronic Obstructive Pulmonary Disease (COPD) Segment to Dominate the Spirometer Market

Based on application, the spirometer market is segmented into Chronic Obstructive Pulmonary Disease (COPD), asthma, cystic fibrosis, pulmonary fibrosis, and other applications. In 2024, the Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometer market. This segment’s large market share can be attributed to the high burden of Chronic Obstructive Pulmonary Disease (COPD). For instance, according to the National Institutes of Health (NIH), in 2022, 300 million people worldwide were diagnosed with COPD.

By End User: In 2024, the Hospitals & Clinics Segment to Dominate the Spirometer Market

Based on end user, the spirometer market is segmented into hospitals & clinics, home care settings, and ambulatory care centers. In 2024, the hospitals & clinics segment is expected to account for the largest share of 53.7% of the spirometer market. This segment’s large market share can be attributed to the high volume of patient visits for the treatment of COPD, asthma, and related emergency visits in hospitals & clinics due to the availability of healthcare professionals & advanced equipment in these healthcare settings.

However, the home care settings segment is projected to register the highest CAGR of 9.5% during the forecast period of 2024-2031. This segment’s growth is driven by the increasing demand for spirometers in home care settings, the availability of spirometers specifically designed for home use, and the rising trend of telehealth and remote monitoring.

Geographical Analysis

By Geography: In 2024, North America to Dominate the Spirometer Market

In 2024, North America is expected to account for the largest share of 41.6% of the spirometer market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to the increasing incidence of respiratory diseases leading to higher hospital admissions, the well-established healthcare sector, and the presence of prominent spirometer companies, such as Hill-Rom Holdings, Inc. (U.S.) and Midmark Corporation (U.S.), in this region.

However, the market in Asia-Pacific is projected to register the highest growth rate of 10.2% during the forecast period. The growth of this regional market can be attributed to the increasing awareness regarding the use of spirometers and the expansion of healthcare infrastructure. Additionally, the increase in respiratory disease awareness programs in countries such as China and India contributes to the market’s growth. For instance, in October 2023, Vallabhbhai Patel Chest Institute (India) launched a COPD awareness program aimed at raising awareness of COPD and supporting ongoing research in this field.

Spirometer Market: Key Companies

The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios and geographic presence and the key growth strategies adopted by them over the past 3–4 years. Some of the key players operating in the spirometer market are Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain).

Spirometer Industry Overview: Latest Developments from Key Industry Players

• In January 2024, NuvoAir Inc. (U.S.) received the U.S. Food and Drug Administration (FDA) 510(k) clearance for NuvoAir, air next wireless spirometer. This spirometer enables people to perform detailed lung function tests in the comfort of their own homes, offering data for ongoing monitoring of diseases like asthma, chronic obstructive pulmonary disease (COPD), and amyotrophic lateral sclerosis (ALS).
• In September 2023, Roundworks Technologies Private Limited (India) received the US Food and Drug Administration (FDA) for its alveoair, a portable digital spirometer. This spirometer provides real-time information to doctors and facilitates timely interventions in respiratory care.
• In March 2021, Vyaire Medical, Inc. (U.S.) launched AioCare, a mobile respiratory spirometry system, to improve respiratory care.

Spirometer Market Research Summary

Key questions answered in the spirometer market report: